SBHMY
Price:
$12.065
Market Cap:
$70.49B
Sino Biopharmaceutical Limited operates as a prominent research and development-centric pharmaceutical conglomerate in the People's Republic of China, functioning as an investment holding company. Its operations are organized into three primary divisions: Modernized Chinese and Chemical Medicines, Investment activities, and other varied business ventures. The firm maintains an extensive product range covering numerous therapeutic categories. Among its offerings are oncology treatments, such as Qingkeshu tablets and Leweixin injections; cardiovascular and cerebrovascular medications, including Kaina and Anrixin tablets; hepatitis remedies like Tianqingganmei injections; and orthopedic solutio...[Read more]
Industry
Biotechnology
IPO Date
2017-09-05
Stock Exchange
OTC
Ticker
SBHMY
According to Sino Biopharmaceutical Limited’s latest financial reports and current stock price. The company's current PE Ratio is 31.75. This represents a change of -241.15% compared to the average of -22.49 of the last 4 quarters.
The mean historical PE Ratio of Sino Biopharmaceutical Limited over the last ten years is 27.45. The current 31.75 PE Ratio has changed 11.47% with respect to the historical average. Over the past ten years (40 quarters), SBHMY's PE Ratio was at its highest in in the September 2024 quarter at 60.11. The PE Ratio was at its lowest in in the December 2022 quarter at -93.41.
Average
27.45
Median
31.33
Minimum
5.70
Maximum
42.70
Discovering the peaks and valleys of Sino Biopharmaceutical Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 543.50%
Maximum Annual PE Ratio = 42.70
Minimum Annual Increase = -86.54%
Minimum Annual PE Ratio = 5.70
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 42.70 | 182.38% |
| 2024 | 15.12 | -60.65% |
| 2023 | 38.42 | 4.74% |
| 2022 | 36.68 | 543.50% |
| 2021 | 5.70 | -86.54% |
| 2020 | 42.35 | 63.01% |
| 2019 | 25.98 | 321.63% |
| 2018 | 6.16 | -84.30% |
| 2017 | 39.25 | 77.21% |
| 2016 | 22.15 | -24.74% |
The current PE Ratio of Sino Biopharmaceutical Limited (SBHMY) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
32.08
5-year avg
27.73
10-year avg
27.45
Sino Biopharmaceutical Limited’s PE Ratio is greater than WuXi Biologics (Cayman) Inc. (22.35), greater than WuXi Biologics (Cayman) Inc. (22.35), greater than Genmab A/S (18.89), less than Innovent Biologics, Inc. (131.97), less than Straumann Holding AG (46.51), less than Straumann Holding AG (46.51), greater than Orion Oyj (17.91), greater than Astellas Pharma Inc. (13.18), greater than Astellas Pharma Inc. (13.18), greater than bioMérieux S.A. (20.47),
| Company | PE Ratio | Market cap |
|---|---|---|
| 22.35 | $16.57B | |
| 22.35 | $16.08B | |
| 18.89 | $15.30B | |
| 131.97 | $17.28B | |
| 46.51 | $21.07B | |
| 46.51 | $20.94B | |
| 17.91 | $21.95B | |
| 13.18 | $26.16B | |
| 13.18 | $24.10B | |
| 20.47 | $8.55B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sino Biopharmaceutical Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sino Biopharmaceutical Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Sino Biopharmaceutical Limited's PE Ratio?
How is the PE Ratio calculated for Sino Biopharmaceutical Limited (SBHMY)?
What is the highest PE Ratio for Sino Biopharmaceutical Limited (SBHMY)?
What is the 3-year average PE Ratio for Sino Biopharmaceutical Limited (SBHMY)?
What is the 5-year average PE Ratio for Sino Biopharmaceutical Limited (SBHMY)?
How does the current PE Ratio for Sino Biopharmaceutical Limited (SBHMY) compare to its historical average?